Current Clinical Applications and Future Perspectives of Immune Checkpoint Inhibitors in Non-Hodgkin Lymphoma

por Apostolidis, John, Sayyed, Ayman, Darweesh, Mohammed, Kaloyannidis, Panayotis, Al Hashmi, Hani
Publicado 2020

Repeated courses of escalating doses of Nivolumab in refractory Hodgkin lymphoma with recurrent relapses post allografting: A safe and effective treatment approach

por Kaloyannidis, Panayotis, Al Shaibani, Eshrak, Moinnudin, Asif, Al Anezi, Khalid, Al Hashmi, Hani
Publicado 2021

Risk Assessment for Newly Diagnosed Fit Young Patients with Multiple Myeloma in the Era of Novel Treatment Modalities: Should There Be Additional Factors Taken into Consideration??

por Kaloyannidis, Panayotis, Abdulla, Fatema, Mutahar, Enas, Al Hashim, Haidar, Al Harbi, Salman, Estanislao, Analie, Al Hashmi, Hani
Publicado 2022

De Novo Psoriasis Vulgaris Diagnosed after Nivolumab Treatment for Refractory Hodgkin's Lymphoma, Completely Resolved after Autologous Hematopoietic Stem Cell Transplantation

por Kaloyannidis, Panayotis, Al Shaibani, Eshrak, Mashhour, Miral, Gamil, Mohammed, Apostolidis, Ioannis, Al Hashmi, Hani, Al Anazi, Khalid Ahmed
Publicado 2018

Saudi Lymphoma Group‘s Clinical Practice Guidelines for Diagnosis, Management and Follow-up of Patients with Various Types of Lymphoma during the Coronavirus Disease 2019 Pandemic...

por Alzahrani, Musa, Al-Mansour, Mubarak M., Apostolidis, John, Barefah, Ahmed, Dada, Reyad, Alhejazi, Ayman, Alayed, Yasir, Motabi, Ibraheem, Radwi, Mansoor, Al-Hashmi, Hani
Publicado 2020

Single-Agent High-Dose Melphalan as Conditioning Regimen in Autologous Hematopoietic Stem Cell Transplantation for Hodgkin's Lymphoma: Safety, and Long-Term Efficacy

por Al Hashmi, Hani, Kaloyannidis, Panayotis, Kafnar, Solaf, Al Harbi, Salman, Shaibani, Eshrak, Mokhtar, Nihad, Abdulbaki, Manar, Al Darweesh, Mohammed, Bacal, Jenifer, Apostolidis, John, Anezi, Khalid Al
Publicado 2018

Establishing hematopoietic stem cell transplant programs; overcoming cost through collaboration

por Al-Hashmi, Hani, Alsagheir, Ahmed, Estanislao, Analie, Bacal, Jenifer, Alsuhebah, Ashraf, Alblowe, Belal, Raslan, Heba, Alsaber, Arwa, Albahrani, Ahmed, Almulhem, Norah, Alamri, Amal, Alsaleh, Khalid, Albeihany, Amal, Alabdulwahab, Amal, Bakkar, Mohammed, Kaloyannidis, Panayotis
Publicado 2020

A National Collaborative Multicenter Phase II Study for Potential Safety Efficacy of Convalescent Plasma to Treat Severe COVID-19 Patients

por Al Hashmi, Hani, Alawami, Deia, Zaidi, Syed Ziauddin A, Alshehry, Nawal F, Alzahrani, Hazza A., Zaidi, Abdul Rehman Z, Al Sagheir, Ahmed, Khojah, Osamah, Alaskar, Ahmed, AlMozain, Noura, Al-Ansari, Rehab, Alfaraj, Mona, ElGohary, Ghada, Dayel, Afra, Bahrani, Ahmed, Abdulhamid, Arwa Nabhan, Alhumaidan, Hind, Albalawi, Mohammed, AlFraedhi, Alia, Al-Otaibi, Jawaher, Abdallah, Rania
Publicado 2020

Addressing Cancer Treatment Shortages in Saudi Arabia: Results of a National Survey and Expert Panel Recommendations

por AlAzmi, Aeshah A., Jastaniah, Wasil, Alhamdan, Hani S., AlYamani, Arwa O., AlKhudhyr, Waleed I., Abdullah, Shaker M., AlZahrani, Mohammed, AlSahafi, Ashraf, AlOhali, Tawfiq A., Alkhelawi, Trad, AlObaida, Yasser, Allam, Ayman, Al-Hashmi, Hani, Murshid, Essam, AlNajjar, Fouad, AlGethami, Ashwag, AlHarbi, Atika, AlFoheidi, Meteb O., AlSaeed, Ahmad S., Elsolh, Hassan, Abosoudah, Ibraheem, Ben Obaid, Abdulaziz, AlNahedh, Mohammed
Publicado 2020

Safety and Efficacy of Convalescent Plasma to Treat Severe COVID-19: Protocol for the Saudi Collaborative Multicenter Phase II Study

por Albalawi, Mohammed, Zaidi, Syed Ziauddin Ahmed, AlShehry, Nawal, AlAskar, Ahmed, Zaidi, Abdul Rehman Zia, Abdallah, Rania Nagib Mohammed, Salam, Abdul, AlSagheir, Ahmed, AlMozain, Nour, Elgohary, Ghada, Batarfi, Khalid, Alfaraedi, Alia, Khojah, Osamah, Al-Ansari, Rehab, Alfaraj, Mona, Dayel, Afra, Al Bahrani, Ahmed, Abdelhameed, Arwa Nabhan, Alhumaidan, Hind, Al-Otaibi, Jawaher M, Radwi, Ghazala, Raizah, Abdulrahman, Shatry, Hind, Alsaleh, Sara, AlZahrani, Hazzaa, Al-Hashmi, Hani
Publicado 2020

Safety and Efficacy of Convalescent Plasma for Severe COVID-19: Interim Report of a Multicenter Phase II Study from Saudi Arabia

por AlShehry, Nawal, Zaidi, Syed Ziauddin A, AlAskar, Ahmed, Al Odayani, Abdurahman, Alotaibi, Jawaher Mubarak, AlSagheir, Ahmed, Al-Eyadhy, Ayman, Balelah, Saud, Salam, Abdul, Zaidi, Abdul Rehman Zia, Alawami, Diea, Alshahrani, Mohammed S., AlMozain, Nour, Abulhamayel, Yem M, Al Qunfoidi, Reem, Alfaraj, Mona, Qushmaq, Nahid, Alansari, Rehab, Dayel, Afra, Elgohary, Ghada, Al Bahrani, Ahmed, Nabhan Abdelhameed, Arwa A., AlZahrani, Hazza Abdullah, Alturkistani, Hanan, AlShehry, Nada, Albalawi, Mohammed Abdulhameed, Elalfy, Ibrahim, Alhumaidan, Hind, Al-Hashmi, Hani
Publicado 2021